使用免疫检查点抑制剂治疗晚期和复发性子宫内膜癌的治疗策略
Ami Jo1, Tadahiro Shoji2, Haruka Otsuka1
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahaba, Iwate, 028-3695, Japan.
International journal of clinical oncology
|January 15, 2025
概括
免疫检查点抑制剂在晚期或复发的子宫内膜癌中表现有前途. 组合疗法和生物标志物导向治疗正在改善患者的治疗结果,并改变治疗模式.
科学领域:
- 妇科瘤学 妇科瘤学
- 医学瘤学 医学瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 对于子宫内膜癌的标准化疗包括多克索鲁比 + 西斯普拉丁和帕克利塔塞尔 + 卡博普拉丁.
- 针对PD-1/PD-L1的免疫检查点抑制剂正在成为子宫内膜癌的有效治疗方法.
- 生物标志物的发展正在使个性化治疗策略成为可能.
研究的目的:
- 审查针对晚期或复发性子宫内膜癌的免疫检查点抑制剂的临床试验.
- 突出免疫疗法在子宫内膜癌治疗中的不断变化的作用.
- 讨论生物标志物引导治疗对治疗结果的影响.
主要方法:
- 临床试验的审查,包括KEYNOTE-775和全球随机的III期研究.
- 对组合疗法 (pembrolizumab + lenvatinib) 和新药 (dostarlimab,durvalumab,atezolizumab) 的数据进行分析.
- 检查生物标志物发展及其临床应用.
主要成果:
- 布罗利祖马布 + 伦瓦替尼在晚期或复发性子宫内膜癌中显示出好处,导致日本的保险覆盖.
- 与对照组相比,III期研究显示了达尔利马布,杜尔瓦卢马布和阿特佐利祖马布的优异结果.
- 生物标志物驱动的方法正在提高治疗疗效.
结论:
- 免疫检查点抑制剂代表了子宫内膜癌治疗的重大进展.
- 免疫疗法从二线到一线治疗的过渡正在进行中.
- 基于生物标志物的个性化治疗策略对于优化子宫内膜癌的结果至关重要.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:30Cancer Vaccines
336
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
336
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K